ArticleSystematic reviews2026
Prevalence of Epstein-Barr virus infection in North African cancer patients: a systematic review and meta-analysis protocol.
Article in Systematic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEpstein-Barr virus (EBV) is a well-recognized oncogenic virus associated with the development of various malignancies. In North Africa, EBV-related cancers, such as nasopharyngeal carcinoma, gastric cancer, and lymphomas, present a significant health challenge due to their high mortality rates. Despite the common occurrence of these malignancies, the prevalence and impact of EBV infection in this context remain largely unexamined. Addressing this knowledge gap is crucial for understanding the virus's role in cancer pathogenesis and for informing effective prevention and treatment strategies.
methodsElectronic databases will be searched for literature published up to 2025 using a Boolean search approach combining common terms and Medical Subject Headings (MeSH) for EBV infection, cancer, and North Africa. The review will only include studies carried out in North Africa that assess the prevalence of EBV infection in patients with cancer. Using the Joanna Briggs Institute (JBI) critical appraisal tools, the quality and potential risk of bias of all selected full-text articles will be evaluated. DISCUSSION: This protocol outlines a systematic review and meta-analysis aiming to evaluate the prevalence of EBV infection in cancer patients in North Africa to better understand its role in the region's cancer burden. Insights from this study will support improved prevention, early detection, and more personalized treatment strategies, ultimately aiding the reduction of cancer mortality in the region. SYSTEMATIC REVIEW REGISTRATION: This protocol has been published in the PROSPERO International Prospective Register of Systematic Reviews ( http://www.crd.york.ac.uk/PROSPERO ), under the registration number CRD42024594373.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.